Similar companies
Income Statement (USD)
| Q2 '24 | QoQ | |
|---|---|---|
| Gross Profit | -2.4M | 3.5% |
| Cost of Revenue | 2.4M | 3.9% |
| Operating expense | 6.3M | 6.1% |
| Net Income | -8.2M | 3.9% |
| EBITDA | -6.3M | 6.1% |
Balance Sheet (USD)
| Q2 '24 | QoQ | |
|---|---|---|
| Total Assets | 46M | 8.4% |
| Total Liabilities | 91M | 4.2% |
| Shares Outstanding | 7M | 0% |
Cash Flow (USD)
| Q2 '24 | QoQ | |
|---|---|---|
| Cash from operations | -3.9M | 35.4% |
EPS
Financial Highlights for Minerva Neurosciences in Q2 '24
Gross Profit stood at -2.4M, marking a 3.5% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 2.4M, a -3.9% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 6.3M, showing a -6.1% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was -8.2M, showing a 3.9% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was -6.3M, showing a 6.1% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
Minerva Neurosciences faced some challenges this quarter with a decline in one or more of the key metrics: revenue, gross profit, or net income. An increase in the cost of revenue, higher than the revenue growth, suggests potential margin pressures.
